AOP Orphan Announces Launch of Access Program for the World's First ...

Albania, Belarus, Belgium, Bosnia & Hercegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Hungary, Kazakhstan, Latvia, Lithuania, Luxembourg, Macedonia, Netherlands, Norway, Poland, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, Sweden, UK, Ukraine Vienna, Austria, August 11, 2015 / B3C newswire / -- AOP Orphan , a pioneering pharmaceutical company in the field of rare diseases, is launching in Europe the world's first drug approved by the FDA that can be used effectively against lipodystrophy , which is widespread among HIV patients: EGRIFTAA .